Nordson Corporation (NASDAQ:NDSN) reported its Q3 results, with EPS of $2.49 coming in better than the Street estimate of $2.44. Revenue was $662 million, compared to the Street estimate of $650.62 million.

Orders strength was broad-based and consistent through the quarter, including consistent strength across industrial short and long-cycle markets. NBS Next continues to leverage database view of clear differentiated opportunities supporting disproportionate investment in target areas, driving continued momentum in areas like biopharma, broadening electronics applications, etc.

The company reiterated its full 2022-year guidance, expecting revenue growth in the range of 8%-9% year-over-year and adjusted EPS growth in the range of 18% to 21%.